SEC Form 4 · accession 0001209191-17-036733
Calithera Biosciences, Inc. · CALA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
MORGENTHALER VENTURE PARTNERS IX LP
10% Owner
Period of report
Jun 1, 2017
Accepted (ET)
Jun 1, 2017 · 2:49 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001496671
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | holding | — | — | — | 2,161,915 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The securities are held by Morgenthaler Venture Partners IX, L.P. ("MVP IX"). The general partner of MVP IX is Morgenthaler Management Partners IX, LLC ("MMP IX"). MMP IX may be deemed to indirectly beneficially own the securities directly held by MVP IX. MMP IX disclaims beneficial ownership of the securities held by MVP IX except to the extent of its pecuniary interest therein.
Remarks
This Form 4 is being filed to disclose that, as a result of the issuance of additional shares of Common Stock by the Issuer, Morgenthaler Venture Partners IX, L.P. ceased to hold 10% of any class of shares of the Issuer's stock as of January 30, 2017.